Researchers report breakthrough inhibition of intestinal tract tumors in mice models

Scientists from the Institute for Fundamental Science (IBS) have successfully inhibited the growth of colon cancers in mice with mismatch repair deficiency. The research team, headed with the Center’s director MYUNG Kyungjae, made the announcement in a manuscript published in the American Association for Cancer Research on June 6th. This is a significant breakthrough for the future treatment of digestive tract cancer patients; specifically for those with DNA mismatch repair (MMR) deficient tumors. Related Posts:Immune cell’s role in intestinal movement may lead to…Combining epigenetic therapies with immunotherapies likely…Cleveland Clinic’s preventive breast cancer vaccine…Fox Chase trial tests promising therapy in early breast…New nanopharmaceutical may help overcome resistance to…The post Researchers report breakthrough inhibition of intestinal tract tumors in mice models appeared first on My Irritable Bowel Syndrome Story.
Source: My Irritable Bowel Syndrome Story - Category: Gastroenterology Authors: Tags: IBS News Source Type: blogs